Home › NDC Lookup › Labelers › Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 54092 (Takeda Pharmaceuticals America, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

37
Package NDCs
35
Products
35
Active listings
0
Discontinued
11
Ingredients
0
Therapeutic classes
10
Dosage forms
25
With NADAC pricing

Portfolio

Top ingredients
carbamazepine 6
Dextroamphetamine Sulfate, Dextroa... 6
lanthanum carbonate 5
MESALAMINE 4
DEXTROAMPHETAMINE SULFATE, DEXTROA... 4
guanfacine 4
PRUCALOPRIDE 2
anagrelide hydrochloride 1
idursulfase 1
velaglucerase alfa 1
By dosage form
CAPSULE, EXTENDED RELEASE 16
TABLET, EXTENDED RELEASE 4
CAPSULE 3
TABLET, CHEWABLE 3
TABLET, DELAYED RELEASE 2
POWDER 2
TABLET, FILM COATED 2
SOLUTION, CONCENTRATE 1

Browse records — 35 products

Drug / product Billing NDC NADAC / unit Status
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0387-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-387-01) 54092-0387-01 $6.806 /unit · NADAC On market View →
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0383-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-383-01) 54092-0383-01 $6.808 /unit · NADAC On market View →
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0389-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-389-01) 54092-0389-01 $6.809 /unit · NADAC On market View →
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0381-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-381-01) 54092-0381-01 $6.828 /unit · NADAC On market View →
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0391-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-391-01) 54092-0391-01 $6.808 /unit · NADAC On market View →
Adderall XR Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0385-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-385-01) 54092-0385-01 $6.814 /unit · NADAC On market View →
Agrylin anagrelide hydrochloride .5 mg/1 CAPSULE Takeda · NDC 54092-0063-01 · 100 CAPSULE in 1 BOTTLE (54092-063-01) 54092-0063-01 — On market View →
Carbatrol carbamazepine 100 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0171-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-171-12) 54092-0171-12 $1.700 /unit · NADAC On market View →
Carbatrol carbamazepine 300 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0173-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-173-12) 54092-0173-12 $1.695 /unit · NADAC On market View →
Carbatrol carbamazepine 200 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0172-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-172-12) 54092-0172-12 $1.694 /unit · NADAC On market View →
Carbatrol carbamazepine 200 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0172-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-172-12) 54092-0172-12 $1.694 /unit · NADAC On market View →
Carbatrol carbamazepine 300 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0173-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-173-12) 54092-0173-12 $1.695 /unit · NADAC On market View →
Carbatrol carbamazepine 100 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0171-12 · 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-171-12) 54092-0171-12 $1.700 /unit · NADAC On market View →
ELAPRASE idursulfase 6 mg/3mL SOLUTION, CONCENTRATE Takeda · NDC 54092-0700-01 · J1743 · 1 VIAL, GLASS in 1 BOX (54092-700-01) / 3 mL in 1 VIAL, GLASS 54092-0700-01 — On market View →
Firazyr icatibant acetate 30 mg/3mL INJECTION, SOLUTION Takeda · NDC 54092-0702-01 · 1 SYRINGE, GLASS in 1 CARTON (54092-702-01) / 3 mL in 1 SYRINGE, GLASS 54092-0702-01 — On market View →
Fosrenol lanthanum carbonate 750 mg/1 TABLET, CHEWABLE Takeda · NDC 54092-0253-90 · 6 BOTTLE in 1 PACKAGE (54092-253-90) / 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15) 54092-0253-90 — On market View →
Fosrenol lanthanum carbonate 1000 mg/1 TABLET, CHEWABLE Takeda · NDC 54092-0254-90 · 9 BOTTLE in 1 PACKAGE (54092-254-90) / 10 TABLET, CHEWABLE in 1 BOTTLE (54092-254-10) 54092-0254-90 — On market View →
Fosrenol lanthanum carbonate 750 mg/1 POWDER Takeda · NDC 54092-0256-02 · 9 CARTON in 1 PACKAGE (54092-256-02) / 10 POWDER in 1 CARTON (54092-256-01) 54092-0256-02 — On market View →
Fosrenol lanthanum carbonate 1000 mg/1 POWDER Takeda · NDC 54092-0257-02 · 9 CARTON in 1 CARTON (54092-257-02) / 10 POWDER in 1 CARTON (54092-257-01) 54092-0257-02 — On market View →
Fosrenol lanthanum carbonate 500 mg/1 TABLET, CHEWABLE Takeda · NDC 54092-0252-90 · 2 BOTTLE in 1 PACKAGE (54092-252-90) / 45 TABLET, CHEWABLE in 1 BOTTLE (54092-252-45) 54092-0252-90 — On market View →
Intuniv guanfacine 2 mg/1 TABLET, EXTENDED RELEASE Takeda · NDC 54092-0515-02 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-515-02) 54092-0515-02 $9.313 /unit · NADAC On market View →
Intuniv guanfacine 1 mg/1 TABLET, EXTENDED RELEASE Takeda · NDC 54092-0513-02 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-513-02) 54092-0513-02 $9.397 /unit · NADAC On market View →
Intuniv guanfacine 3 mg/1 TABLET, EXTENDED RELEASE Takeda · NDC 54092-0517-02 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-517-02) 54092-0517-02 $9.294 /unit · NADAC On market View →
Intuniv guanfacine 4 mg/1 TABLET, EXTENDED RELEASE Takeda · NDC 54092-0519-02 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-519-02) 54092-0519-02 $9.291 /unit · NADAC On market View →
Lialda mesalamine 1.2 g/1 TABLET, DELAYED RELEASE Takeda · NDC 54092-0476-01 · 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01) 54092-0476-01 $8.949 /unit · NADAC On market View →
Mesalamine 1.2 g/1 TABLET, DELAYED RELEASE Takeda · NDC 54092-0100-01 · 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-100-01) 54092-0100-01 $0.795 /unit · NADAC On market View →
MOTEGRITY PRUCALOPRIDE 2 mg/1 TABLET, FILM COATED Takeda · NDC 54092-0547-01 · 30 TABLET, FILM COATED in 1 BOTTLE (54092-547-01) 54092-0547-01 $17.750 /unit · NADAC On market View →
MOTEGRITY PRUCALOPRIDE 1 mg/1 TABLET, FILM COATED Takeda · NDC 54092-0546-01 · 30 TABLET, FILM COATED in 1 BOTTLE (54092-546-01) 54092-0546-01 $17.725 /unit · NADAC On market View →
MYDAYIS DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE 3.125 mg/1; 3.125 mg/1; 3.125 mg/1; 3.125 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0468-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-468-01) 54092-0468-01 $10.759 /unit · NADAC On market View →
MYDAYIS DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE 9.375 mg/1; 9.375 mg/1; 9.375 mg/1; 9.375 mg/1 CAPSULE, EXTENDED RELEASE Takeda · NDC 54092-0474-01 · 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-474-01) 54092-0474-01 $10.755 /unit · NADAC On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.